Recombinant interferon-inducible protein-10
Alternative Names: rIP-10Latest Information Update: 30 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Cytostatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Leukaemia
Most Recent Events
- 07 Sep 1998 Profile reviewed
- 12 Aug 1996 Preclinical development for Leukaemia in USA (Unknown route)